For a world eagerly waiting to be freed from the suffocating COVID-19 pandemic, Sinovac is becoming a household name. The small Chinese company is planning to produce 1 billion doses of its vaccine, and inoculations have begun in some of the poorest and most populous nations on three continents. While a leader in China in vaccine development, Sinovac is largely unknown to much of the world. In "Conquering COVID," author Peter Halesworth uses his seven years of experience with the company to provide an in-depth look at its rough-and-tumble history, its turbulent present, and its breakthrough in developing a vaccine that promises to help end a global pandemic.